Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2008
12/24/2008WO2008157374A1 High-affinity monoclonal antibodies for botulinum toxin type a
12/24/2008WO2008157325A2 Devices, systems, and methods for measuring glucose
12/24/2008WO2008157311A2 5-bromo-2'-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same
12/24/2008WO2008157302A2 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling
12/24/2008WO2008157299A2 Differential expression profiling analysis of cell culture phenotypes and uses thereof
12/24/2008WO2008157277A1 Methods for evaluating breast cancer prognosis
12/24/2008WO2008157220A1 Methods and apparatus for the isolation and enrichment of circulating tumor cells
12/24/2008WO2008157120A1 Method and apparatus for removal of vaporized hydrogen peroxide from a region
12/24/2008WO2008157079A1 Biosensor and ultrasonic method of making a biosensor
12/24/2008WO2008157003A2 Chemical inhibitors of bfl-1 and related methods
12/24/2008WO2008156865A2 Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
12/24/2008WO2008156858A2 Use of pre-mrna splicing in platelet cells for the diagnosis of disease
12/24/2008WO2008156752A2 Vitreous biomarkers and related diagnostics and therapeutics
12/24/2008WO2008156720A1 Electrophoretic tag-based in vitro assay to quantify dimerization of p66 and p51 subunits of hiv-1 reverse transcriptase (rt)
12/24/2008WO2008156662A1 Methods of diagnosing non-alcoholic steatohepatitis (nash)
12/24/2008WO2008156650A2 Device, kit and method for hookworm antigen capture and detection
12/24/2008WO2008156648A1 Roundworm coproantigen detection
12/24/2008WO2008156629A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells
12/24/2008WO2008156617A2 Methods and kits for predicting treatment response in type ii diabetes mellitus patients
12/24/2008WO2008156613A1 Histone h2ax (hh2ax) biomarker for fti sensitivity
12/24/2008WO2008156561A1 Methods and compositions for the treatment and diagnosis of statin-induced myopathy
12/24/2008WO2008156510A2 Method for functionalizing materials and devices comprising such materials
12/24/2008WO2008156491A2 Devices and methods for analysis of samples with depletion of analyte content
12/24/2008WO2008156428A2 Novel peptides and protein and uses thereof
12/24/2008WO2008156418A1 A method for screening or diagnosis of postpolio syndrome and fibromyalgia
12/24/2008WO2008156415A1 Rapid fungal detection assay and product
12/24/2008WO2008156363A1 Selective inhibitors of the nuclear factor of activated t-cells
12/24/2008WO2008156183A1 Hepatocellular carcinoma protein marker, and method for detection of hepatocellular carcinoma using the same
12/24/2008WO2008156151A1 Simulation method, simulation apparatus, biological treatment method and biological treatment apparatus
12/24/2008WO2008156135A1 Method of measuring microparticles having nucleic acid and apparatus therefor
12/24/2008WO2008156083A1 Method for measuring bonding activity of antibody which mimics antibody-dependent cell-mediated cytotoxic activity
12/24/2008WO2008156069A1 Screening method for antibody and antibody obtained by the method
12/24/2008WO2008155924A1 Glucose dehydrogenase
12/24/2008WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1
12/24/2008WO2008155891A1 Novel marker for arteriosclerotic disease
12/24/2008WO2008155778A2 Assay for detection of transient intracellular ca2+
12/24/2008WO2008155692A2 Molecular conformation biosensing
12/24/2008WO2008155579A1 Monitoring an immunoassay
12/24/2008WO2008155556A1 A method for assaying fto (2-oxoglutarate dependent oxygenase) activity
12/24/2008WO2008155529A1 Compositions
12/24/2008WO2008155524A1 Freeze-dried compositions for carrying out pcr and other biochemical reactions
12/24/2008WO2008155519A1 Method of operating a fluidic device and a fluidic device for use in the method
12/24/2008WO2008155467A1 Transmembrane prostatic acid phosphatase
12/24/2008WO2008155397A2 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
12/24/2008WO2008155396A1 Method for testing a subject thought to have or to be predisposed to asthma
12/24/2008WO2008155330A1 Diagnostic substance and method for the diagnosis of prostate diseases
12/24/2008WO2008155128A2 Method and device for positioning and optionally aligning an object
12/24/2008WO2008154981A1 Paramagnetic oxygen measurement cell
12/24/2008WO2008154813A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
12/24/2008WO2008154738A1 Azapeptides as cd36 binding compounds
12/24/2008WO2008137910A3 Matrix stabilization of aggregation-based assays
12/24/2008WO2008135639A3 Novel useful inhibitors
12/24/2008WO2008132656A3 A biosensor chip and a method of manufacturing the same
12/24/2008WO2008132384A3 Analysis kit comprising at least two molecularly imprinted polymers and at least one marker, and method of analysis using same
12/24/2008WO2008130926A3 Characterization of n-glycans using exoglycosidases
12/24/2008WO2008130614A3 Selective and dual-action p53/mdm2/mdm4 antagonists
12/24/2008WO2008130432A3 Nanoscale spintronic chemical sensor
12/24/2008WO2008128043A3 Diagnostic and prognostic methods for renal cell carcinoma
12/24/2008WO2008127403A3 Biopolymer optofluidic device and method of manufacturing the same
12/24/2008WO2008118831A3 Droplet actuator loading and target concentration
12/24/2008WO2008118386A3 Method for detecting autoprocessed, secreted pcsk9
12/24/2008WO2008116233A3 A method for determining the content of metallic elements in fischer-tropsch waxes
12/24/2008WO2008116044A8 SEMICONDUCTOR QUANTUM DOTS FOR EFEICIENT DELIVERY AND INTRACELLULAR IMAGING OF siRNA
12/24/2008WO2008115518A3 Biomarkers of sirtuin activity and methods of use thereof
12/24/2008WO2008112840A3 Novel composition and methods for the treatment of immune related diseases
12/24/2008WO2008109832A3 Viable near-infrared fluorochrome labeled cells and methods of making and using same
12/24/2008WO2008106104A3 Environmentally sensitive fluorophores
12/24/2008WO2008101184A3 Arl-1 specific antibodies
12/24/2008WO2008101154A3 Immunotherapy for immune suppressed patients
12/24/2008WO2008097632A9 Methods for determining splice variant types and amounts
12/24/2008WO2008097491A3 Biomarkers of ionizing radiation response
12/24/2008WO2008097360A3 Polymeric nanopillars and nanotubes, their manufacture and uses
12/24/2008WO2008091306B1 Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses
12/24/2008WO2008082974A3 Non-denaturing lysis reagent
12/24/2008WO2008078831A8 Biosensor, biosensor chip and method for producing the biosensor chip for sensing a target molecule
12/24/2008WO2008070301A3 Predicting lung cancer survival using gene expression
12/24/2008WO2008063406A3 A platform for binding assays with dual multiplexing capability
12/24/2008WO2008061095A3 Clip based sampling of seed for the removal of specific seed tissue or structures for seed analysis
12/24/2008WO2008060941A3 Expression system of nell peptide
12/24/2008WO2008060576A3 Spicematrix technology for taste compound identification
12/24/2008WO2008057767A3 Reduction of non-specific binding in immunoassays
12/24/2008WO2008057652A3 A method to detect virus related immunological markers for the diagnosis of hepatitis c virus infection
12/24/2008WO2008054764A3 Biomarkers for colorectal cancer
12/24/2008WO2008051949A3 Gpr125 as a marker for stem and progenitor cells and methods use thereof
12/24/2008WO2008048570A3 Piwil2-related biomarkers and cell lines useful therewith
12/24/2008WO2008042806A3 Stilbenedisulfonic acid derivatives as inhibitors of retroviral integrase
12/24/2008WO2008040994A3 Fluoro-substituted benzoxazole polymethine dyes
12/24/2008WO2008033535A3 Amine-reactive biosensor
12/24/2008WO2008027459A3 Detecting a bacterial process in chronic rhinosinusitis
12/24/2008WO2008024763A3 Identification and characterization of hcv replicon variants with reduced susceptibility to hcv-796, and methods related thereto
12/24/2008WO2008013910A3 Methods for identifying, diagnosing, and predicting survival of lymphomas
12/24/2008WO2008009002A3 Reagents for the detection of protein phosphorylation in signaling pathways
12/24/2008WO2008008998A3 Reagents for the detection of protein phosphorylation in signaling pathways
12/24/2008WO2008008553A3 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
12/24/2008WO2008005674A3 Methods of analyzing binding interactions
12/24/2008WO2007140696A8 Elisa kit for detecting sudan red and method thereof
12/24/2008WO2007140401A3 Method of operating an analyte separation instrument
12/24/2008WO2007130636A3 Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
12/24/2008WO2007109013A3 Method for genetic selection of high-plasmid producing e. coli clones
12/24/2008WO2007095126A3 Assays to predict atherosclerosis and dysfunctional high-density lipoprotein